{"transactions":[{"id":676240,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-08-25T23:09:24.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":1734,"price":3.8569,"value":6687.8646,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":367456,"source":{"system":"sec-edgar","filing":"0001869194-26-000011","document":"wk-form4_1787699362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000011/wk-form4_1787699362.xml","form_type":"4"}},{"id":676239,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-08-25T23:09:24.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":2430,"price":3.8569,"value":9372.267,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":369190,"source":{"system":"sec-edgar","filing":"0001869194-26-000011","document":"wk-form4_1787699362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000011/wk-form4_1787699362.xml","form_type":"4"}},{"id":676238,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-08-25T23:09:24.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":3089,"price":3.8569,"value":11913.9641,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":371620,"source":{"system":"sec-edgar","filing":"0001869194-26-000011","document":"wk-form4_1787699362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000011/wk-form4_1787699362.xml","form_type":"4"}},{"id":676237,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-08-25T23:09:24.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":3486,"price":3.8569,"value":13445.1534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":374709,"source":{"system":"sec-edgar","filing":"0001869194-26-000011","document":"wk-form4_1787699362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000011/wk-form4_1787699362.xml","form_type":"4"}},{"id":730668,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:01:35.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":31000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001869194-26-000008","document":"wk-form4_1782158491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000008/wk-form4_1782158491.xml","form_type":"4"}},{"id":730667,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:01:35.000Z","date":"2026-06-18","kind":"sale","planned":true,"acquired":false,"shares":81898,"price":5.989,"value":490487.122,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Transaction was executed in multiple trades in prices ranging from $5.97 to $6.0086, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":378195,"source":{"system":"sec-edgar","filing":"0001869194-26-000008","document":"wk-form4_1782158491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000008/wk-form4_1782158491.xml","form_type":"4"}},{"id":730666,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-06-22T20:01:35.000Z","date":"2026-06-18","kind":"exercise","planned":true,"acquired":true,"shares":31000,"price":0.99,"value":30690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026."}],"balance_after":460093,"source":{"system":"sec-edgar","filing":"0001869194-26-000008","document":"wk-form4_1782158491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000008/wk-form4_1782158491.xml","form_type":"4"}},{"id":766204,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:09:08.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":1418,"price":6.2675,"value":8887.315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":429093,"source":{"system":"sec-edgar","filing":"0001869194-26-000006","document":"wk-form4_1779480546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000006/wk-form4_1779480546.xml","form_type":"4"}},{"id":766203,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:09:08.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":1911,"price":6.2675,"value":11977.1925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":430511,"source":{"system":"sec-edgar","filing":"0001869194-26-000006","document":"wk-form4_1779480546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000006/wk-form4_1779480546.xml","form_type":"4"}},{"id":766202,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:09:08.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":2157,"price":6.2675,"value":13518.9975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":432422,"source":{"system":"sec-edgar","filing":"0001869194-26-000006","document":"wk-form4_1779480546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000006/wk-form4_1779480546.xml","form_type":"4"}},{"id":766201,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:09:08.000Z","date":"2026-05-21","kind":"sale","planned":false,"acquired":false,"shares":1503,"price":6.2675,"value":9420.0525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":434579,"source":{"system":"sec-edgar","filing":"0001869194-26-000006","document":"wk-form4_1779480546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000006/wk-form4_1779480546.xml","form_type":"4"}},{"id":888243,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-24T01:47:47.000Z","date":"2026-02-20","kind":"sale","planned":false,"acquired":false,"shares":984,"price":5.7138,"value":5622.3792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":436082,"source":{"system":"sec-edgar","filing":"0001610717-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071726000062/form4.xml","form_type":"4"}},{"id":888242,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-24T01:47:47.000Z","date":"2026-02-20","kind":"sale","planned":false,"acquired":false,"shares":7192,"price":5.865,"value":42181.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":437066,"source":{"system":"sec-edgar","filing":"0001610717-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071726000062/form4.xml","form_type":"4"}},{"id":931232,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Patient Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T21:23:02.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":124040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":124040,"derivative":{"exercise_price":7.77,"expiration_date":"2036-01-23","underlying":"Common Stock","underlying_shares":124040},"source":{"system":"sec-edgar","filing":"0001610717-26-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071726000020/form4.xml","form_type":"4"}},{"id":931231,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:23:02.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":82695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":444258,"source":{"system":"sec-edgar","filing":"0001610717-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071726000020/form4.xml","form_type":"4"}},{"id":942284,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T23:59:45.000Z","date":"2026-01-08","kind":"exercise","planned":true,"acquired":false,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":62000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001869194-26-000002","document":"wk-form4_1768003182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000002/wk-form4_1768003182.xml","form_type":"4"}},{"id":942283,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-01-09T23:59:45.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":6.978,"value":348900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $6.97 to $7.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan in August 2025."}],"balance_after":361563,"source":{"system":"sec-edgar","filing":"0001869194-26-000002","document":"wk-form4_1768003182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000002/wk-form4_1768003182.xml","form_type":"4"}},{"id":942282,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-01-09T23:59:45.000Z","date":"2026-01-08","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":0.99,"value":49500.0,"ownership":{"direct":true},"balance_after":409896,"source":{"system":"sec-edgar","filing":"0001869194-26-000002","document":"wk-form4_1768003182.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000186919426000002/wk-form4_1768003182.xml","form_type":"4"}},{"id":988813,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2025-11-25T21:35:34.000Z","date":"2025-11-21","kind":"sale","planned":false,"acquired":false,"shares":6426,"price":5.5369,"value":35580.1194,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":359896,"source":{"system":"sec-edgar","filing":"0001610717-25-000394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071725000394/form4.xml","form_type":"4"}},{"id":1053711,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T23:30:25.000Z","date":"2025-08-26","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001628280-25-041339","document":"wk-form4_1756423821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025041339/wk-form4_1756423821.xml","form_type":"4"}},{"id":1053710,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2025-08-28T23:30:25.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":6.121,"value":183630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":366322,"source":{"system":"sec-edgar","filing":"0001628280-25-041339","document":"wk-form4_1756423821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025041339/wk-form4_1756423821.xml","form_type":"4"}},{"id":1053709,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2025-08-28T23:30:25.000Z","date":"2025-08-26","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":6.121,"value":306050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $6.04 to $6.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":396322,"source":{"system":"sec-edgar","filing":"0001628280-25-041339","document":"wk-form4_1756423821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025041339/wk-form4_1756423821.xml","form_type":"4"}},{"id":1053708,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2025-08-28T23:30:25.000Z","date":"2025-08-26","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":0.99,"value":49500.0,"ownership":{"direct":true},"balance_after":446322,"source":{"system":"sec-edgar","filing":"0001628280-25-041339","document":"wk-form4_1756423821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025041339/wk-form4_1756423821.xml","form_type":"4"}},{"id":1056899,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2025-08-26T01:13:45.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":6261,"price":5.9317,"value":37138.3737,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":396322,"source":{"system":"sec-edgar","filing":"0001628280-25-041139","document":"wk-form4_1756170821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025041139/wk-form4_1756170821.xml","form_type":"4"}},{"id":1137446,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-23T01:55:29.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":6421,"price":4.0814,"value":26206.6694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":402583,"source":{"system":"sec-edgar","filing":"0001628280-25-027433","document":"wk-form4_1747965323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025027433/wk-form4_1747965323.xml","form_type":"4"}},{"id":1240968,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-27T23:06:19.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":157700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 25, 2025, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":157700,"derivative":{"exercise_price":5.18,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":157700},"source":{"system":"sec-edgar","filing":"0001628280-25-008810","document":"wk-form4_1740697572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025008810/wk-form4_1740697572.xml","form_type":"4"}},{"id":1240967,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-27T23:06:19.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":105200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":409004,"source":{"system":"sec-edgar","filing":"0001628280-25-008810","document":"wk-form4_1740697572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025008810/wk-form4_1740697572.xml","form_type":"4"}},{"id":1253218,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-21T23:56:25.000Z","date":"2025-02-20","kind":"sale","planned":false,"acquired":false,"shares":4941,"price":5.623,"value":27783.243,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Transaction was executed in multiple trades in prices ranging from $5.601611 to $5.625428, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":303804,"source":{"system":"sec-edgar","filing":"0001628280-25-007234","document":"wk-form4_1740182178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828025007234/wk-form4_1740182178.xml","form_type":"4"}},{"id":1354628,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-22T23:37:42.000Z","date":"2024-11-20","kind":"sale","planned":false,"acquired":false,"shares":7366,"price":4.7945,"value":35316.287,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 1,371 shares under the Ardelyx Employee Stock Purchase Plan in August 2024."}],"balance_after":308745,"source":{"system":"sec-edgar","filing":"0001628280-24-049057","document":"wk-form4_1732318656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024049057/wk-form4_1732318656.xml","form_type":"4"}},{"id":1425586,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-08-22T22:28:03.000Z","date":"2024-08-20","kind":"sale","planned":false,"acquired":false,"shares":7412,"price":5.8603,"value":43436.5436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":314740,"source":{"system":"sec-edgar","filing":"0001628280-24-038296","document":"wk-form4_1724365676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024038296/wk-form4_1724365676.xml","form_type":"4"}},{"id":1487131,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T22:29:35.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":251000,"derivative":{"exercise_price":2.75,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001628280-24-027351","document":"wk-form4_1717799368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024027351/wk-form4_1717799368.xml","form_type":"4"}},{"id":1487130,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-07T22:29:35.000Z","date":"2024-06-05","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":7.125,"value":712500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $7.11 to $7.145, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":322152,"source":{"system":"sec-edgar","filing":"0001628280-24-027351","document":"wk-form4_1717799368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024027351/wk-form4_1717799368.xml","form_type":"4"}},{"id":1487129,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-07T22:29:35.000Z","date":"2024-06-05","kind":"sale","planned":false,"acquired":false,"shares":45000,"price":7.124,"value":320580.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $7.11 to $7.145, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":422152,"source":{"system":"sec-edgar","filing":"0001628280-24-027351","document":"wk-form4_1717799368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024027351/wk-form4_1717799368.xml","form_type":"4"}},{"id":1487128,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-06-07T22:29:35.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":2.75,"value":275000.0,"ownership":{"direct":true},"balance_after":467152,"source":{"system":"sec-edgar","filing":"0001628280-24-027351","document":"wk-form4_1717799368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024027351/wk-form4_1717799368.xml","form_type":"4"}},{"id":1503862,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-23T20:21:28.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":4794,"price":7.811,"value":37445.934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 1,757 shares under the Ardelyx Employee Stock Purchase Plan in February 2024."}],"balance_after":367152,"source":{"system":"sec-edgar","filing":"0001628280-24-024955","document":"wk-form4_1716495670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024024955/wk-form4_1716495670.xml","form_type":"4"}},{"id":1524914,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-07T20:48:10.000Z","date":"2024-05-03","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":162000,"derivative":{"exercise_price":0.99,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001610717-24-000230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071724000230/form4.xml","form_type":"4"}},{"id":1524913,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-07T20:48:10.000Z","date":"2024-05-03","kind":"sale","planned":true,"acquired":false,"shares":39949,"price":8.35,"value":333574.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":370189,"source":{"system":"sec-edgar","filing":"0001610717-24-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071724000230/form4.xml","form_type":"4"}},{"id":1524912,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-07T20:48:10.000Z","date":"2024-05-03","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":0.99,"value":29700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023."}],"balance_after":410138,"source":{"system":"sec-edgar","filing":"0001610717-24-000230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071724000230/form4.xml","form_type":"4"}},{"id":1625679,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:56:07.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":4803,"price":8.7463,"value":42008.4789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":380138,"source":{"system":"sec-edgar","filing":"0001610717-24-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000161071724000080/form4.xml","form_type":"4"}},{"id":1676585,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T21:39:32.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":152127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":152127,"derivative":{"exercise_price":8.78,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":152127},"source":{"system":"sec-edgar","filing":"0001628280-24-001692","document":"wk-form4_1705613951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024001692/wk-form4_1705613951.xml","form_type":"4"}},{"id":1676584,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-18T21:39:32.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":118750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":384941,"source":{"system":"sec-edgar","filing":"0001628280-24-001692","document":"wk-form4_1705613951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828024001692/wk-form4_1705613951.xml","form_type":"4"}},{"id":1731467,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-11-22T22:22:01.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":2581,"price":4.3622,"value":11258.8382,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 1,933 shares under the Ardelyx Employee Stock Purchase Plan in August 2023."}],"balance_after":266191,"source":{"system":"sec-edgar","filing":"0001628280-23-039907","document":"wk-form4_1700691709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828023039907/wk-form4_1700691709.xml","form_type":"4"}},{"id":1737070,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-11-17T22:30:24.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":3.9999,"value":99997.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $3.97 to $4.045, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":266839,"source":{"system":"sec-edgar","filing":"0001628280-23-039528","document":"wk-form4_1700260214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828023039528/wk-form4_1700260214.xml","form_type":"4"}},{"id":1798805,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-23T20:46:32.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":2591,"price":3.5518,"value":9202.7138,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $3.5135 to $3.551843, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":291839,"source":{"system":"sec-edgar","filing":"0001628280-23-030412","document":"wk-form4_1692823583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828023030412/wk-form4_1692823583.xml","form_type":"4"}},{"id":1842097,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-29T23:22:29.000Z","date":"2023-06-27","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":3.3453,"value":83632.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades in prices ranging from $3.331 to $3.365, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":294430,"source":{"system":"sec-edgar","filing":"0001628280-23-023956","document":"wk-form4_1688080938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000162828023023956/wk-form4_1688080938.xml","form_type":"4"}},{"id":1878360,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-25T12:51:50.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":2583,"price":3.6532,"value":9436.2156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan in February 2023."}],"balance_after":319430,"source":{"system":"sec-edgar","filing":"0001104659-23-064386","document":"tm2316962-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000110465923064386/tm2316962-1_4seq1.xml","form_type":"4"}},{"id":1993607,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-24T22:41:39.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":3187,"price":3.001,"value":9564.187,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":319013,"source":{"system":"sec-edgar","filing":"0001567619-23-003774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761923003774/doc1.xml","form_type":"4"}},{"id":2060707,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T21:23:33.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":351000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":351000,"derivative":{"exercise_price":2.73,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":351000},"source":{"system":"sec-edgar","filing":"0001567619-23-000640","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761923000640/doc1.xml","form_type":"4"}},{"id":2060706,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-06T21:23:33.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (\"RSUs\"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof."}],"balance_after":322200,"source":{"system":"sec-edgar","filing":"0001567619-23-000640","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761923000640/doc1.xml","form_type":"4"}},{"id":2105464,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-23T21:13:15.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":1193,"price":1.9493,"value":2325.5149,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":244200,"source":{"system":"sec-edgar","filing":"0001567619-22-020844","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761922020844/doc1.xml","form_type":"4"}},{"id":2105463,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-23T21:13:15.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":33,"price":1.945,"value":64.185,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":245393,"source":{"system":"sec-edgar","filing":"0001567619-22-020844","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761922020844/doc1.xml","form_type":"4"}},{"id":2105462,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-23T21:13:15.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":15,"price":1.9416,"value":29.124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":245426,"source":{"system":"sec-edgar","filing":"0001567619-22-020844","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761922020844/doc1.xml","form_type":"4"}},{"id":2169126,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-01T23:03:38.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":3000,"price":0.6188,"value":1856.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022."}],"balance_after":245441,"source":{"system":"sec-edgar","filing":"0001567619-22-016957","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761922016957/doc1.xml","form_type":"4"}},{"id":2175086,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-08-24T21:42:51.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":13,"price":0.9801,"value":12.7413,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":242441,"source":{"system":"sec-edgar","filing":"0001567619-22-016642","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761922016642/doc1.xml","form_type":"4"}},{"id":2175085,"issuer":{"id":4972,"kind":"organization","name":"ARDELYX, INC."},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-08-24T21:42:51.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":1263,"price":0.9837,"value":1242.4131,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."}],"balance_after":242454,"source":{"system":"sec-edgar","filing":"0001567619-22-016642","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000156761922016642/doc1.xml","form_type":"4"}},{"id":2245208,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-04T00:22:18.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant."}],"balance_after":8500,"derivative":{"exercise_price":1.07,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-22-034392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000120919122034392/doc4.xml","form_type":"4"}},{"id":2650525,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":19946,"kind":"person","name":"Williams Laura A","position":1,"cik":"0001869194","reported_name":"Williams Laura A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-30T21:18:11.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":15457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal installments on June 29, 2022, 2023 and 2024."}],"balance_after":15457,"derivative":{"exercise_price":8.12,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":15457},"source":{"system":"sec-edgar","filing":"0001209191-21-043999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869194/000120919121043999/doc4.xml","form_type":"4"}}]}